Region: Canada

Huawei’s FRAND strategy: move cases to China

The company wants to shift disputes to its home jurisdiction and persuade courts there to set a low, China-specific rate

27 September 2019

Nanjing judge sets Chinese SEP rate in dispute between Conversant and Huawei

Chinese court has had its say on royalties - and it looks like the telecoms giant has got exactly what it was looking for

23 September 2019

WiLAN patent purchase shows semiconductor space remains a happy hunting ground for NPEs

Deal with Mediatek involves package of global families and comes months after Canadian licensing company’s deal with Nvidia

20 September 2019

Born from business need

How business, innovation and intellectual property are evolving together at TD Bank

30 August 2019

How TD Bank embraced patents to ensure it maximised the benefits of the fintech revolution

The Canadian institution is among the industry players to have transformed its approach to IP, but the banking sector still has a fight on its hands to keep up with the tech giants

12 August 2019

Canadian IP initiative aims to kick-start a revolution

Although it is home to many big ticket patent players, Canada has lagged in encouraging SMEs to maximise the value of the rights they own; new programme designed to reverse that trend

06 August 2019

The companies that lead the race for blockchain patents revealed

IBM and NChain are the only non-Chinese entities that feature in the nine-strong list of first tier applicants

24 July 2019

Canadian antenna firm scores Delhi injunction win

Court borrows from past wireless cases to institute a deposit scheme for the first time in a non-SEP case. The defendant will need to shell out 10% of its past sales in India to avoid sales disruption in latest pro-plaintiff decision

15 July 2019

Sonos’s “foundational” IP faces another challenge as it files suit against rival

Looking once again to use its portfolio to protect its market position, the speaker company accuses Canadian rival of infringing multiple patents

21 June 2019

$1 billion Keytruda deal illustrates value of royalty right sales for research institutes

Transformative agreement shows why niche investment model may appeal to cash-strapped life sciences innovators

30 May 2019

Unlock unlimited access to all IAM content